Last Chance: Get 30 Days of MarketBeat All Access for FREE, then just $399 $199 for the year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
EXTENDED - TODAY ONLY: MarketBeat All Access For Just $399 $199 (save 50%)
×
S&P 500   3,973.01 (+0.23%)
DOW   33,912.37 (+0.19%)
QQQ   282.61 (-0.04%)
AAPL   143.77 (-0.31%)
MSFT   240.84 (-0.38%)
META   109.84 (+0.97%)
GOOGL   95.27 (-0.81%)
AMZN   93.36 (-0.63%)
TSLA   185.43 (+1.37%)
NVDA   158.25 (-0.01%)
NIO   10.88 (+7.51%)
BABA   80.32 (+5.85%)
AMD   73.97 (+1.07%)
T   18.89 (+0.37%)
MU   56.15 (+0.72%)
CGC   3.43 (+0.88%)
F   13.83 (+0.73%)
GE   85.49 (+0.02%)
DIS   95.78 (+0.09%)
AMC   7.38 (+0.68%)
PYPL   80.17 (+0.30%)
PFE   49.49 (-0.16%)
NFLX   281.13 (-0.01%)
S&P 500   3,973.01 (+0.23%)
DOW   33,912.37 (+0.19%)
QQQ   282.61 (-0.04%)
AAPL   143.77 (-0.31%)
MSFT   240.84 (-0.38%)
META   109.84 (+0.97%)
GOOGL   95.27 (-0.81%)
AMZN   93.36 (-0.63%)
TSLA   185.43 (+1.37%)
NVDA   158.25 (-0.01%)
NIO   10.88 (+7.51%)
BABA   80.32 (+5.85%)
AMD   73.97 (+1.07%)
T   18.89 (+0.37%)
MU   56.15 (+0.72%)
CGC   3.43 (+0.88%)
F   13.83 (+0.73%)
GE   85.49 (+0.02%)
DIS   95.78 (+0.09%)
AMC   7.38 (+0.68%)
PYPL   80.17 (+0.30%)
PFE   49.49 (-0.16%)
NFLX   281.13 (-0.01%)
S&P 500   3,973.01 (+0.23%)
DOW   33,912.37 (+0.19%)
QQQ   282.61 (-0.04%)
AAPL   143.77 (-0.31%)
MSFT   240.84 (-0.38%)
META   109.84 (+0.97%)
GOOGL   95.27 (-0.81%)
AMZN   93.36 (-0.63%)
TSLA   185.43 (+1.37%)
NVDA   158.25 (-0.01%)
NIO   10.88 (+7.51%)
BABA   80.32 (+5.85%)
AMD   73.97 (+1.07%)
T   18.89 (+0.37%)
MU   56.15 (+0.72%)
CGC   3.43 (+0.88%)
F   13.83 (+0.73%)
GE   85.49 (+0.02%)
DIS   95.78 (+0.09%)
AMC   7.38 (+0.68%)
PYPL   80.17 (+0.30%)
PFE   49.49 (-0.16%)
NFLX   281.13 (-0.01%)
S&P 500   3,973.01 (+0.23%)
DOW   33,912.37 (+0.19%)
QQQ   282.61 (-0.04%)
AAPL   143.77 (-0.31%)
MSFT   240.84 (-0.38%)
META   109.84 (+0.97%)
GOOGL   95.27 (-0.81%)
AMZN   93.36 (-0.63%)
TSLA   185.43 (+1.37%)
NVDA   158.25 (-0.01%)
NIO   10.88 (+7.51%)
BABA   80.32 (+5.85%)
AMD   73.97 (+1.07%)
T   18.89 (+0.37%)
MU   56.15 (+0.72%)
CGC   3.43 (+0.88%)
F   13.83 (+0.73%)
GE   85.49 (+0.02%)
DIS   95.78 (+0.09%)
AMC   7.38 (+0.68%)
PYPL   80.17 (+0.30%)
PFE   49.49 (-0.16%)
NFLX   281.13 (-0.01%)

Fortress Biotech - FBIO Price Target & Analyst Ratings

$0.68
-0.01 (-2.10%)
(As of 11/29/2022 10:16 AM ET)
Add
Compare
Today's Range
$0.68
$0.70
50-Day Range
$0.68
$0.90
52-Week Range
$0.67
$2.96
Volume
800 shs
Average Volume
121,408 shs
Market Capitalization
$73.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.50

Fortress Biotech Consensus Rating and Price Target (2022)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Buy
Based on 5 Analyst Ratings

Consensus Analyst Price Target

$9.50
1,292.76% Upside
High Prediction$20.00
Average Prediction$9.50
Low Prediction$6.00
TypeCurrent
11/29/21 to 11/29/22
1 Month Ago
10/30/21 to 10/30/22
3 Months Ago
8/31/21 to 8/31/22
1 Year Ago
11/29/20 to 11/29/21
Consensus Rating
Buy
Buy
Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
5 Buy rating(s)
6 Buy rating(s)
5 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$9.50$9.50$9.60$11.00
Predicted Upside1,292.76% Upside626.97% Upside484.14% Upside205.80% Upside
Get Fortress Biotech Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for FBIO and its competitors with MarketBeat's FREE daily newsletter.


FBIO Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

FBIO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Fortress Biotech Stock vs. The Competition

TypeFortress BiotechMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.66
2.48
Consensus RatingBuyBuyHold
Predicted Upside1,263.57% Upside746.65% Upside14.69% Upside
News Sentiment RatingVery Positive News
Positive News
Neutral News
MarketBeat
Community Rating
Outperform Votes
316
67.81%
Underperform Votes
150
32.19%
Avg. Outperform Votes
164
66.40%
Avg. Underperform Votes
83
33.60%
Avg. Outperform Votes
853
68.19%
Avg. Underperform Votes
398
31.81%

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
8/4/2022LADENBURG THALM/SH SH
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$6.00+500.00%
7/14/2022B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$8.00 ➝ $6.00+582.66%
5/13/2022Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Jennifer Kim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy$6.00+599.05%
3/29/2022Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Henry
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
12/7/2021UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingPositive$20.00+703.21%
10/8/2021HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Joseph Pantginis
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy$10.00+234.45%
2/17/2021Dawson James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$16.00 ➝ $21.00+444.04%
10/2/2020Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$9.00 ➝ $9.00+123.32%
(Data available from 11/29/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












FBIO Price Target - Frequently Asked Questions

What is Fortress Biotech's consensus rating and price target?

According to the issued ratings of 5 analysts in the last year, the consensus rating for Fortress Biotech stock is Buy based on the current 5 buy ratings for FBIO. The average twelve-month price prediction for Fortress Biotech is $9.50 with a high price target of $20.00 and a low price target of $6.00. Learn more on FBIO's analyst rating history.

Do Wall Street analysts like Fortress Biotech more than its competitors?

Analysts like Fortress Biotech more than other Medical companies. The consensus rating score for Fortress Biotech is 3.00 while the average consensus rating score for medical companies is 2.66. Learn more on how FBIO compares to other companies.

Do MarketBeat users like Fortress Biotech more than its competitors?

MarketBeat users like Fortress Biotech more than other Medical companies. 67.81% of MarketBeat users gave Fortress Biotech an outperform vote while medical companies recieve an average of 66.40% outperform votes by MarketBeat users.

Does Fortress Biotech's stock price have much upside?

According to analysts, Fortress Biotech's stock has a predicted upside of 626.97% based on their 12-month price targets.


Stock Ratings Reports and Tools

This page (NASDAQ:FBIO) was last updated on 11/29/2022 by MarketBeat.com Staff